EORTC announces new governance with new Board of Directors and President-Elect
The summer holidays are nearly here, and we are just concluding a series [...]
EORTC in the spotlight at ASCO 2021
EORTC studies were well-represented at this year’s ASCO conference, which [...]
EORTC selected abstracts at ASCO 2021
ASCO Annual Meeting will take place virtually from 4 to [...]
PRESS RELEASE: Sanofi partnering with leading academic cooperative groups to study amcenestrant in the adjuvant setting for patients with estrogen receptor positive breast cancer GalleryPRESS RELEASE: Sanofi partnering with leading academic cooperative groups to study amcenestrant in the adjuvant setting for patients with estrogen receptor positive breast cancer
PRESS RELEASE: Sanofi partnering with leading academic cooperative groups to study amcenestrant in the adjuvant setting for patients with estrogen receptor positive breast cancer
Sanofi partnering with the Breast International Group (BIG), the European [...]
Analysis of EORTC treatment optimisation studies shows their value to patients and healthcare providers
The current evidence gap between pre- and post-authorisation stages of [...]
Revisiting classification in testicular cancer: what has changed?
Two papers* on testicular cancer from the International Germ Cell [...]
Prof. Dr. A (Ton) Hagenbeek (1948 – 2021)
Professor of Hematology, Academic Medical Center (AMC) , Dept. of [...]
EORTC will facilitate cancer clinical trials, says the Porto Declaration on Cancer Research
EORTC Director General Dr Denis Lacombe spoke on “Quality assurance [...]
EORTC Gastrointestinal Cancer Group launches its Young Investigators & Early Career Investigators’ Program for 2021
The EORTC Gastrointestinal Group cordially invites you to apply for [...]
PRESS RELEASE: HSH Prince Albert II cedes Honorary Presidency of the EORTC Research Fund to HRH Princess Dina Mired
Brussels, April 20th, 2021 – The European Organisation for Research [...]
